Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer

被引:0
|
作者
Qiu, Yu [1 ,2 ]
Chen, Yan [1 ,2 ]
Shen, Haoyang [1 ,2 ]
Yan, Shuixin [1 ,2 ]
Li, Jiadi [1 ,2 ]
Wu, Weizhu [1 ,3 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315000, Peoples R China
[2] Ningbo Univ, Hlth Sci Ctr, Ningbo 315000, Zhejiang, Peoples R China
[3] Affiliated Lihuili Hosp, 1111 Jiangnan Rd, Ningbo 315000, Zhejiang, Peoples R China
关键词
triple-negative breast cancer; Naples prognostic score; prognostic factor; nomogram predictive model; INFLAMMATION;
D O I
10.2147/JIR.S472917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: This study investigated the correlation between the Naples prognostic score (NPS), clinicopathological traits, and the postoperative prognoses of patients with triple-negative breast cancer (TNBC). Based on NPS, a predictive nomogram was developed to estimate the long-term survival probabilities of patients with TNBC post-surgery. Patients and Methods: We retrospectively examined the clinical records of 223 women with TNBC treated at Ningbo Medical Center, Lihuili Hospital between January 1, 2016 and December 31, 2020. Blood tests and biochemical analyses were conducted before surgery. The prognostic nutritional index (PNI), controlling nutritional status (CONUT), neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and NPS were determined based on blood-related markers. A Kaplan-Meier survival analysis assessed the association between NPS, PNI, CONUT score, overall survival (OS), and breast cancer-specific survival (BCSS). Predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUC) and C index. The patients were randomly divided into the training and the validation group (6:4 ratio). A nomogram prediction model was developed and evaluated using the R Software for Statistical Computing (RMS) package. Results: NPS outperformed other scores in predicting inflammation outcomes. Patients with an elevated NPS had a poorer prognosis (P<0.001). Lymph node ratio (LNR), surgical method, postoperative chemotherapy, and NPS independently predicted OS, whereas M stage, LNR, and NPS independently predicted BCSS outcome. The OS and BCSS predicted by the nomogram model aligned well with the actual OS and BCSS. The decision curve analysis showed significant clinical utility for the nomogram model. Conclusion: In this study, NPS was an important prognostic indicator for patients with TNBC. The nomogram prognostic model based on NPS outperformed other prognostic scores for predicting patient prognosis. The model demonstrated a clear stratification ability for patient prognosis, which emphasized the potential benefits of early intervention for high-risk patients. Plain Language Summary: In this study, we aimed to understand how the Naples prognostic score (NPS) scoring system could predict the prognosis for patients with triple-negative breast cancer (TNBC). TNBC is a type of breast cancer that can be difficult to treat. Medical records of 223 women with TNBC were retrospectively analyzed. These women had their blood tested before surgery to check for certain markers related to nutrition and inflammation. NPS was used along with other scores to determine their accuracy in predicting survival. NPS was better at predicting outcomes than the other scores. The patients with higher NPS scores tended to have poorer outcomes. We also created a visual tool called a nomogram to help doctors predict patient outcomes based on the NPS scores. NPS can be a valuable tool for doctors treating patients with TNBC because it can help them predict how well a patient might do after surgery. This information could be used to tailor treatment plans for these patients. The nomogram provides a user-friendly way for doctors to use NPS in their practice. Overall, this study showed that NPS is a powerful tool for predicting outcomes for patients with TNBC, which could lead to better treatment decisions and improved outcomes for these patients.
引用
下载
收藏
页码:5253 / 5269
页数:17
相关论文
共 50 条
  • [31] Clinicopathologic and Prognostic Characteristics of Triple-Negative Breast Cancer
    Tian, Xing-song
    Cong, Ming-hua
    Zhou, Wen-hong
    Zhu, Jian
    Chen, Yue-zhi
    Liu, Qi
    ONKOLOGIE, 2008, 31 (11): : 610 - 614
  • [32] Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer
    Kim, Kwang-Min
    Choi, Hyang Suk
    Noh, Hany
    Cho, In-Jeong
    Lim, Seung Taek
    Lee, Jong-In
    Han, Airi
    JOURNAL OF BREAST CANCER, 2021, 24 (05) : 443 - 454
  • [33] Triple-Negative Breast Cancer: A Comparison of Race and Survival
    Doepker, Matthew P.
    Holt, Scott D.
    Durkin, Martin W.
    Chu, Christopher H.
    Nottingham, James M.
    AMERICAN SURGEON, 2018, 84 (06) : 881 - 888
  • [34] Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
    Kuo, Wen-Hung
    Chang, Yao-Yin
    Lai, Liang-Chuan
    Tsai, Mong-Hsun
    Hsiao, Chuhsing Kate
    Chang, King-Jen
    Chuang, Eric Y.
    PLOS ONE, 2012, 7 (09):
  • [35] The Epidemiology, Clinico-Pathologic and Prognostic Characteristics of Triple-Negative Breast Cancer Compared with Non Triple-Negative Breast Cancer
    Kwong, A.
    Wong, K.
    Wong, C. H. N.
    Leung, C.
    CANCER RESEARCH, 2009, 69 (24) : 669S - 669S
  • [36] A novel three-long noncoding RNA risk score system for the prognostic prediction of triple-negative breast cancer
    Yuan, Chao
    Yuan, Hongjun
    Chen, Li
    Sheng, Miaomiao
    Tang, Wenru
    BIOMARKERS IN MEDICINE, 2021, 15 (01) : 43 - 55
  • [37] Prognostic role of triple-negative subtype in breast cancer patients with brain metastases
    Mathew, A.
    Rosenzweig, M. Q.
    Brufsky, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [38] Pathologic and immunohistochemical prognostic score in residual triple-negative breast cancer after neoadjuvant chemotherapy
    Ilie, S. M.
    Arnould, L.
    Briot, N.
    Desmoulins, I.
    Hennequin, A.
    Kaderbhai, C.
    Bertaut, A.
    Coutant, C.
    Causeret, S.
    Loustalot, C.
    Ilie, A.
    Derangere, V.
    Ladoire, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S432 - S432
  • [39] Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer
    Choi, Y. S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S709 - S710
  • [40] The prognostic value of androgen receptor expression in triple-negative breast cancer patients
    Haggag, R. M.
    Abu-Taleb, F. M.
    Elsayed, H.
    Shiha, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S1436 - S1436